summit tirzepatide Has Scaled the HFpEF/Obesity SUMMIT? Tirzepatide for HFPEF and Obesity

SKU: 61289270196

Pay in 4 interest-free payments of $7.31 Learn more

Live Spec

Tirzepatide for HFPEF and Obesity SUMMIT Prof. Dr. Barry A Borlaug (Rochester, MN, USA) YouTube Tirzepatide: First Approval Drugs Springer Nature Link JACC #ACC25: A recent #JACC publication on the SUMMIT trial evaluates tirzepatide in patients with #HFpEF, with secondary analyses focusing on (1) cardiac structure and (2) #CKD. https: bit.ly 3EdDCQK Facebook Tirzepatide's Prediabetes Triumph Cardiac Wire SURMOUNT 1 Trial Cardionerds Twitter Journal Club Effects of tirzepatide on circulatory overload and end organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial Nature Medicine

Store: www.ab-travaux.com · Domain: www.ab-travaux.com